<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03564743</url>
  </required_header>
  <id_info>
    <org_study_id>14/E/20</org_study_id>
    <nct_id>NCT03564743</nct_id>
  </id_info>
  <brief_title>Description of Spondylarthritis and Validation of ASAS Criteria in West Indian Patients Seen in Consultation of Rheumatology.</brief_title>
  <acronym>SPACA</acronym>
  <official_title>Clinical Description of Spondylarthritis and Validation of Assessment of SpondyloArthritis International Society (ASAS) Criteria in West Indian Patients Seen in the Routine Consultation of Rheumatology.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Center of Martinique</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Center of Martinique</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In 2004 an ASAS for the Assessment of SpondyloArthritis International Society decided to work
      to improve the criteria for classification of spondyloarthropathies to allow for early
      diagnosis, Nuclear magnetic resonance imaging (MRI). This approach led to the publication in
      2009 of the classification criteria for spondylarthritis, in particular axial
      spondyloarthritis, as well as a proposal to modify the classification of criteria defined by
      Mr. Amor (AMOR) and European Spondylarthropathy Study Group (ESSG) criteria, taking into
      account the potential abnormalities visible in Magnetic Resonance Imaging Nuclear (MRI).

      The performance (specificity, sensitivity, positive and negative predictive values) of the
      ASAS criteria was then prospectively tested on a sample of the Metropolitan Caucasian
      population and this systematic study allowed to estimate the performance of the ASAS criteria
      in the usual framework Of the French Liberal Rheumatology Consultation.

      Note that this approach is exposed to a criticism of &quot;circular&quot; approach, indeed the expert
      who is the gold standard for the diagnosis, uses more or less consciously &quot;criteria&quot; based on
      the presence of such and such sign, then checks in this selected population the diagnostic
      validity of these signs.

      However, no data on the performance of ASAS criteria are available in populations of African
      descent.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Historically, spondyloarthritis is considered rare in these populations in the image of human
      Leukocyte Antigen B27 (HLA B27) which is observed only in 0.3% of individuals. Its presence
      determines the appearance of sacroiliitis - the cardinal sign of the disease - which is
      therefore rare. The recent contribution of MRI has changed investigators point of view and
      makes it possible to make the diagnosis in frequent situations but more atypical clinically.

      In practice:

        1. ASAS signs are not systematically found in the West Indies (sacroiliitis, uveitis,
           cervicitis, urethritis, inflammatory syndrome, HLAB27 ...)

        2. Apart from cases associated with Chronic Inflammatory Bowel Disease (IBD), clinical
           panels are atypical and the ASAS criteria for little help

        3. MRI imaging is used to correct diagnosis. It is therefore necessary to describe these
           patients and to study the interest of the ASAS criteria in this population On the other
           hand, the validation of the ASAS criteria is part of the recommendations of treatment of
           the SPA (spondyloarthritis) by the French Society of Rheumatology in 2014. Clearly a
           patient who does not validate these criteria does not have access to anti- tumor
           necrosis factor (TNF) biotherapies, effective but Expensive. Thus, it is not known
           whether West Indian patients validate these criteria or not, but it is clear that
           despite the large number of local SPAs, few receive anti-TNF biotherapies.

      The investigators propose to describe a population of Caribbean spondyloarthritis through a
      cross-sectional observational study carried out with a sample of rheumatologist doctors in
      three sites (Martinique, Guadeloupe, French Guyana). The methodology of the cluster survey of
      physicians, with a systematic evaluation of the first patients seen in consultation
      (chronological selection) provides the best guarantee of representativeness.

      The interest of this work is to reproduce exactly the methodology of a previous work carried
      out in a Caucasian population, validated and published, and thus be able to compare the value
      of the ASAS criteria between the Caucasian and Caribbean populations.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 2015</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">November 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants with treatment-related adverse events as assessed by CTCAE v4.0</measure>
    <time_frame>September 2018</time_frame>
    <description>Number of Participants With Treatment-Related Adverse Events as Assessed by CTCAE v4.0, Change From Baseline in Pain Scores on the Visual Analog Scale at 6 Weeks.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ASAS criteria</measure>
    <time_frame>September 2018</time_frame>
    <description>Assess the performance of ASAS criteria (sensitivity, specificity, positive predictive value, negative predictive value) at the time of physician's diagnosis of chronic low back pain in rheumatological practice (Evaluation of the concept of &quot;diagnostic criteria&quot; and Classification criteria).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessment and comparison of ASAS performance against other classifications</measure>
    <time_frame>September 2018</time_frame>
    <description>Performance calculation of other classification systems (ESSG, Amor, New York modified): sensitivity, specificity, positive and negative predictive values.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Spondyloarthritis</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Evaluation of ASAS criteria</intervention_name>
    <description>Perform ASAS criteria at the time of physician diagnosis of chronic low back pain in rheumatological practice.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patient with presence or history of chronic low back pain (≥ 3 months) that started before
        the age of 45 with an onset of low back pain after 2005
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient over 18 years of age

          -  Patient seen in the usual framework of the consultation of rheumatology

          -  Patients consulting with:

          -  Presence or history of chronic low back pain (≥ 3 months) that started before the age
             of 45 with an onset of low back pain after 2005:

          -  Or with known sacroiliitis or asymmetric inflammatory rheumatism

          -  Or with chronic inflammatory bowel disease (Crohn, ulcerative colitis (RCH) ...) and
             associated inflammatory rheumatism

          -  Patients who received a lumbosacral MRI after 2005

          -  Patient not participating in a clinical trial

        Exclusion criteria:

          -  Patient under 18 years of age

          -  Patient participating in another clinical trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michel MD De Bandt</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Martinique</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michel MD De Bandt, PHD</last_name>
    <phone>0596 55 23 31</phone>
    <phone_ext>+596</phone_ext>
    <email>micheldebandt@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marie MB Blettery, MD</last_name>
    <phone>0596 55 23 31</phone>
    <phone_ext>+596</phone_ext>
    <email>marie.blettery@chu-martinique.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU de Martinique</name>
      <address>
        <city>Fort-de-France</city>
        <zip>97261</zip>
        <country>Martinique</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Véronique Mr ERDUAL</last_name>
      <phone>0596592696</phone>
      <phone_ext>+596</phone_ext>
      <email>veronique.erdual@chu-martinique.com</email>
    </contact>
    <investigator>
      <last_name>Michel Mr De Bandt, PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Martinique</country>
  </location_countries>
  <reference>
    <citation>Gran JT. An epidemiological survey of the signs and symptoms of ankylosing spondylitis. Clin Rheumatol. 1985 Jun;4(2):161-9.</citation>
    <PMID>3159533</PMID>
  </reference>
  <reference>
    <citation>Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, Cats A, Dijkmans B, Olivieri I, Pasero G, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum. 1991 Oct;34(10):1218-27.</citation>
    <PMID>1930310</PMID>
  </reference>
  <reference>
    <citation>Amor B, Dougados M, Mijiyawa M. [Criteria of the classification of spondylarthropathies]. Rev Rhum Mal Osteoartic. 1990 Feb;57(2):85-9. French.</citation>
    <PMID>2181618</PMID>
  </reference>
  <reference>
    <citation>van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984 Apr;27(4):361-8.</citation>
    <PMID>6231933</PMID>
  </reference>
  <reference>
    <citation>Sieper J, van der Heijde D, Landewé R, Brandt J, Burgos-Vagas R, Collantes-Estevez E, Dijkmans B, Dougados M, Khan MA, Leirisalo-Repo M, van der Linden S, Maksymowych WP, Mielants H, Olivieri I, Rudwaleit M. New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Ann Rheum Dis. 2009 Jun;68(6):784-8. doi: 10.1136/ard.2008.101501. Epub 2009 Jan 15.</citation>
    <PMID>19147614</PMID>
  </reference>
  <reference>
    <citation>Boy FN, Kayhan A, Karakas HM, Unlu-Ozkan F, Silte D, Aktas İ. The role of multi-parametric MR imaging in the detection of early inflammatory sacroiliitis according to ASAS criteria. Eur J Radiol. 2014 Jun;83(6):989-996. doi: 10.1016/j.ejrad.2014.03.002. Epub 2014 Mar 22.</citation>
    <PMID>24703519</PMID>
  </reference>
  <reference>
    <citation>Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315-24.</citation>
    <PMID>3358796</PMID>
  </reference>
  <reference>
    <citation>Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Ménard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovský J, Wolfe F, Hawker G. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010 Sep;62(9):2569-81. doi: 10.1002/art.27584.</citation>
    <PMID>20872595</PMID>
  </reference>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>April 19, 2017</study_first_submitted>
  <study_first_submitted_qc>June 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 21, 2018</study_first_posted>
  <last_update_submitted>June 11, 2020</last_update_submitted>
  <last_update_submitted_qc>June 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Spondyloarthritis</keyword>
  <keyword>ASAS criteria</keyword>
  <keyword>Diagnosis criteria</keyword>
  <keyword>Classification criteria</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spondylarthritis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

